Rob Binns
Director of Finance/CFO at HOPEFIELD VENTURES TWO INC.
Net worth: 29 500 $ as of 30/04/2024
Profile
Rob Binns is currently the Chief Financial Officer at Hopefield Ventures Two, Inc. He previously worked as the General Manager-Prince Edward Operations at Genzyme Corp., the Chief Operating Officer at Diagnostic Chemicals Ltd., the Chief Financial Officer at ScreenScape Networks, Inc., and the Controller at BioVectra, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
11/01/2023 | 500,000 ( 5.89% ) | 29 500 $ | 30/04/2024 |
Rob Binns active positions
Companies | Position | Start |
---|---|---|
HOPEFIELD VENTURES TWO INC. | Director of Finance/CFO | - |
Former positions of Rob Binns
Companies | Position | End |
---|---|---|
ScreenScape Networks, Inc.
ScreenScape Networks, Inc. Internet Software/ServicesTechnology Services ScreenScape Networks, Inc. develops digital signage software that helps businesses connect and control screens over the Internet. Its customers can turn any screen into a connected digital sign by using plug and play device. The firm’s platform is used by the brand makers and retail networks to publish digital signage content on screens inside their stores. The company was founded by Mark Hemphill in 2007 and is headquartered in Charlottetown, Canada. | Director of Finance/CFO | - |
Diagnostic Chemicals Ltd.
Diagnostic Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Diagnostic Chemicals Ltd. manufactures pharmaceutical products. The private company is based in Charlottetown, Canada. | Chief Operating Officer | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HOPEFIELD VENTURES TWO INC. | Finance |
Private companies | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Diagnostic Chemicals Ltd.
Diagnostic Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Diagnostic Chemicals Ltd. manufactures pharmaceutical products. The private company is based in Charlottetown, Canada. | Health Technology |
ScreenScape Networks, Inc.
ScreenScape Networks, Inc. Internet Software/ServicesTechnology Services ScreenScape Networks, Inc. develops digital signage software that helps businesses connect and control screens over the Internet. Its customers can turn any screen into a connected digital sign by using plug and play device. The firm’s platform is used by the brand makers and retail networks to publish digital signage content on screens inside their stores. The company was founded by Mark Hemphill in 2007 and is headquartered in Charlottetown, Canada. | Technology Services |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
- Stock Market
- Insiders
- Rob Binns